Elevation Point Wealth Partners LLC Buys Shares of 2,748 Cigna Group $CI

Elevation Point Wealth Partners LLC purchased a new position in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 2,748 shares of the health services provider’s stock, valued at approximately $758,000.

Other hedge funds have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Cedar Mountain Advisors LLC grew its position in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Cigna Group in the second quarter worth about $29,000. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group during the 4th quarter worth about $29,000. Finally, Prosperity Bancshares Inc acquired a new position in shares of Cigna Group during the 4th quarter worth about $29,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently commented on CI. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Barclays raised their target price on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, UBS Group raised their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $339.45.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is currently owned by company insiders.

Cigna Group Trading Up 1.0%

Shares of CI opened at $280.32 on Tuesday. The stock has a fifty day moving average price of $283.92 and a two-hundred day moving average price of $281.48. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a market cap of $74.07 billion, a price-to-earnings ratio of 11.60, a PEG ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the prior year, the business earned $7.20 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.